European Journal of Organic Chemistry
10.1002/ejoc.201601034
FULL PAPER
(CH), 127.4 (2 × CH), 128.6 (2 × CH), 132.5 (CH), 166.7 (C), 167.3 (C),
170.4 (C) ppm.
at 70 oC ): δ = 2.16 (m, 1H, 4-Ha), 2.57 (m, 1H, 4-Hb), 3.63 (m, 1H, 5-Ha),
3.68 (m, 1H, 5-Hb), 4.22 (d, J = 4.4 Hz, 1H, 3-H), 5.20 (br s, 2H,
OCH2Ph), 5.77 (br s, 1H, 2-H), 7.37-7.29 (m, 5H, Ar) ppm; 13C NMR
(125.7 MHz, CDCl3, 26 oC): δ = major rotamer 26.5 (CH), 34.0 (CH2),
44.8 (CH2), 67.3 (CH2), 89.8 (CH), 127.8 (2 × CH), 128. 1 (CH), 128.5 (2
× CH), 136.1 (C), 155.6 (C) ppm; minor rotamer 27.4 (CH), 33.0 (CH2),
45.1 (CH2), 67.3 (CH2), 89.2 (CH), 127.8 (2 × CH), 128. 2 (CH), 128.6 (2
× CH), 136.1 (C), 154.3 (C) ppm; MS (EI, 70 eV): m/z (%) = 329 (6) [M+
H2O], 91 (100) [PhCH2]+
Methyl N-(N-(Benzyloxycarbonyl)-L-alanyl)-2-(acetoxy)glycine (27).
Table 4, entry 4. A solution of dipeptide Cbz-Ala-Ser-OMe 25 (65 mg,
0.20 mmol) in dry dichloroethane (3 mL) was treated according to
Method A during 60 min. After usual workup, the residue was purified by
rotatory chromatography on silica gel (hexanes:EtOAc, 30:70), yielding
compound 27 (27 mg, 38%) as a white solid. Table 4, entry 5. A
solution of substrate 25 (65 mg, 0.2 mmol) in DCE (3 mL) was treated
according to Method B during 15 min. Usual workup and purification
yielded starting material (22 mg, 34%) and compound 27 (37 mg, 53%;
yield with respect to transformed starting material 78%). Table 4, entry 6.
A solution of substrate 25 (65 mg, 0.2 mmol) in DCE (3 mL) was treated
according to Method C during 15 min. Usual workup and purification
yielded starting material (20 mg, 31%) and compound 27 (35 mg, 50%;
yield with respect to transformed starting material 71%) as a white solid;
m.p. 103104 °C (n-hexane/EtOAc); IR (CHCl3): nu(tilde) = 3427, 3319,
N-Benzyloxycarbonyl-phenylalanyl-2S/R-allylpyrrolidine (34). Table
5, entry 4. A solution of Cbz-Phe-Pro-OH 32 (79 mg, 0.2 mmol) in
dichloroethane (3 mL) was treated according to Method A during 90 min.
Then the irradiation stopped and the reaction mixture was cooled to 0 oC
and treated with allyltrimethylsilane (0.10 mL, 0.6 mmol) and BF3OEt2
(0.05 mL, 0.4 mmol), and the reaction mixture was stirred for 3 h. Then it
was poured into aqueous saturated NaHCO3 with 5% sodium thiosulfate,
and extracted with dichloromethane. The organic layer was dried over
Na2SO4, filtered and evaporated as before. The residue was purified by
rotatory chromatography on silica gel (hexanes:EtOAc, 70:30) giving the
allylated product 34 (52 mg, 66%). Table 3, entry 5. A solution of Cbz-
Phe-Pro-OH 32 (79 mg, 0.2 mmol) in dichloroethane (3 mL) was treated
according to Method B during 15 min. Then the irradiation stopped and
the reaction mixture was cooled to 0 oC and treated with the allylTMS and
BF3OEt2 as described in entry 4. Usual workup and purification afforded
product 34 (56 mg, 71%). Table 3, entry 6. A solution of Cbz-Phe-Pro-
OH 32 (79 mg, 0.2 mmol) in dichloroethane (3 mL) was treated according
to Method C during 15 min. Then the reaction mixture was cooled to 0 oC
and treated with the allylTMS and BF3OEt2 as described in entry 4. After
usual workup and purification, product 34 (61 mg, 78%) was isolated as
;
3022, 2955, 1753, 1705 cm–1 1H NMR (500 MHz, CDCl3, 70 oC, 1:1
diastereomer mixture): δ = RMN 1H (500 MHz, CDCl3, 26 oC): δH
1.39/1.40 ( [d, J = 6.9 Hz/ d, J = 6.9 Hz], 1H, 2’-Me), 2.07/2.09 (s/s, 3H,
Ac), 3.78/3.80 (s/s, 3H, OMe), 4.34 (m, 1H, 2’-H), 5.11 (d, J = 13 Hz, 1H,
OCHaPh), 5.13 (d, J = 13.5 Hz, 1H, OCHbPh), 5.37 (br b, 1H, NH), 6.39
(d, J = 6.1 Hz, 1H, OCHaN), 6.40 (d, J = 6.3 Hz, 1H, OCHbN), 7.267.38
(m, 5H, Ar), 7.56/7.60 (br b., 1H, NH) ppm; 13C NMR (100.6 MHz, CDCl3)
diastereomer mixture: δC = 18.1/18.3 (CH3), 20.5 (CH3), 50.4 (CH), 53.3
(CH3), 67.2 (CH2), 72.1 (CH), 128.1 (2 × CH), 128.2 (CH), 128.5 (2 × CH),
136.0 (C), 156.0 (C), 166.9 (C), 170.1 (C), 172.4 (C) ppm; MS (EI, 70
eV): m/z (%) = 234 (2) [M+ + H COPh], 233 (13) [M+ COPh], 217 (20)
[M+ H NHCOPh], 213 (26) [M+ COOBn], 189 (71) [M+ COOBn],
105 (48) [PhCO], 91 (100) [C7H7]; HRMS: calc. for C13H17N2O2, 233.1290,
found 233.1287; calc. for C12H15N2O 203.1184, found 203.1186.
C19H20N2O3 (324): C 54.54, H 5.72, N 7.95; found C 54.67, H 5.87, N
7.76.
an oil; IR (CHCl3): nu(tilde) = 3428, 1715, 1636, 1504, 1452 cm–1
;
1H
o
NMR (500 MHz, CDCl3, 70 C, 4:1 diastereomer mixture): Major isomer:
δ = 1.50 (m, 1H, 3-Ha), 1.65-1.70 (m, 2H, 4-H2), 1.80 (m, 1H, 3-Hb), 2.15
(m, 1H, 1‘-Ha), 2.59 (m, 1H, 1‘-Hb), 2.76 (ddd, J = 7.8, 7.9, 8.5 Hz, 1H, 5-
Ha), 3.02 (d, J = 13.6 Hz, 1H, 3‘‘-Ha), 3.06 (d, J = 13.5 Hz, 1H, 3‘‘-Hb),
3.40 (m, 1H, 5-Hb), 4.07 (m, 1H, 2-H), 4.68 (m, 1H, 2‘‘-H), 5.06 (d, J = 9.3
Hz, 1H, 3‘-Ha), 5.08 (d, J = 9.2 Hz, 1H, 3‘-Hb), 5.12 (d, J = 12.5 Hz, 1H,
OCHa), 5.16 (d, J = 12.3 Hz, 1H, OCHb), 5.58 (br b, 1H, NH), 5.76 (dddd,
J = 7.2, 7.2, 7.3, 7.4 Hz, 1H, 2‘-H), 7.217.42 (m, 10H, 2 x Ar); Minor
isomer: δ = 1.50-2.00 (m, 6H, 3-H2 + 4-H2 + 1‘-H2), 3.04 (m, 1H, 3‘‘-Ha),
3.22 (m, 1H, 3‘‘-Hb), 3.38 (m, 1H, 5-Ha), 3.67 (m, 1H, 5-Hb), 4.29 (m, 1H,
2-H), 4.73 (m, 1H, 2‘-H), 5.005.18 (m, 4H, OCH2 + 3‘-H2), 5.37 (br b, 1H,
NH), 5.63 (m, 1H, 2‘-H), 7.217.42 (m, 10H, 2 x Ar) ppm; 13C NMR
(125.7 MHz, CDCl3, 70 oC): Two diastereomers, most signals
overlapped: δ = 23.4 (CH2), 28.5 (CH2), 37.1 (CH2), 39.9 (CH2), 46.6
(CH2), 54.3/54.4 (CH), 57.0 (CH), 66.8 (CH2), 117.1 (CH2), 126.9 (CH),
127.9 (CH), 128.0 (CH), 128.4 (CH x 4), 129.5 (3 x CH), 134.7 (CH),
136.6/136.7 (C x 2), 155.6 (C), 169.6 (C) ppm; MS (EI, 70 eV): m/z (%) =
392 (1) [M+], 351 (1) [M+ CH2CH=CH2], 243 (27) [M+ CbzNH], 91 (72)
[PhCH2]+, 70 (100) [dihydropyrrole +H]+ ppm; HRMS: calc. for
C24H28N2O3 392.2100, found 392.2094; calc. for C21H23N2O3 351.1709,
found 351.1713; calc. for C16H21NO 243.1623, found 243.1620; calc. for
C7H7 91.0548, found 91.0545; calc. for C4H8N 70.0657, found 70.0659.
C24H28N2O3 (392): C 73.44, H 7.19, N 7.14; found C 73.46, H 7.14, N
7.39.
Benzyl 2-hydroxypyrrolidin-1-carboxylate (30)13 and Benzyl 2,3-trans
2-hydroxy-3-iodopyrrolidin-1-carboxylate (31).14 Table 5, Entry 1. A
solution of commercial 1-(benzyloxycarbonyl)proline 2813 (50 mg, 0.2
mmol) in DCE (3 mL) was treated according to Method A for 90 min.
After usual workup and purification by rotatory chromatography
(hexanes:EtOAc 90:10), known products 3013 (25 mg, 56%) and 3114 (10
mg, 14%) were isolated. Table 5, Entry 2. A solution of substrate 28 (50
mg, 0.2 mmol) in DCE (3 mL) was treated according to Method B for 10
min. After usual workup and purification, products 30 (34 mg, 76%) and
31 (5 mg, 7%) were isolated. Table 5, Entry 3. A solution of substrate 28
(50 mg, 0.2 mmol) in DCE (3 mL) was treated according to Method C for
10 min. After usual workup and purification, products 30 (36 mg, 82%)13
and 31 (2 mg, 3%)14 were isolated as oils. Their spectroscopic data
matched those reported in the literature.
Compound 30: IR (CHCl3): nu(tilde) = 3448, 3015, 1698 cm–1
;
1H NMR
o
(500 MHz, CDCl3, 26 C, 2:1 rotamer mixture): δ = 1.75-1.82 (m, 1H, 4-
Ha), 1.80-1.95 (m, 2H, 3-H2), 1.99-2.14 (m, 1H, 4-Hb), 3.32 (m, 1H, CHaN),
3.56 (m, 1H, CHbN), 5.13/5.17 (2H, s/s, OCH2Ph), 5.47/5.52 (1H, [d, J =
5.1 Hz/ br s], 2-H), 7.27-7.40 (5H, m, Ar) ppm; 13C NMR (125.7 MHz,
o
CDCl3, 26 C): δ = 21.0 (CH3), 25.2 (CH3), 26.4 (CH3), 26.7 (CH3), 27.0
(CH3), 66.2 (CH2), 71.1 (CH), 74.1 (CH), 81.3 (CH), 96.7 (CH), 109.7 (C),
113.6 (C), 159.9 (CH), 170.0 (C) ppm; MS (EI, 70 eV): m/z (%) = 203
(18) [M+ H2O], 108 (12) [PhCH2OH]+, 91 (100) [PhCH2]+
Compound 31: IR (CHCl3): nu(tilde) = 3585, 3408, 1700, 1416 cm–1
;
1H
NMR (500 MHz, CDCl3, 70 oC, 2:1 rotamer mixture at 26oC, one rotamer
This article is protected by copyright. All rights reserved